1Miyake K, Tango T, Ota Y, et al. Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis [J]. J Gastroenterol Hepatol, 2002;17(11):1198-204.
2Baltina LA. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine [J]. Curr Med Chem, 2003 ;10(2):155-171.
3Miyaji C, Miyakawa R, Watanabe H, et al. Mechanisms underlying the activation of cytotoxic function mediated by hepatic lymphocytes following the administration of glycyrrhizin [J]. Int Immunopharmacol, 2002;2(8):1079-1086.
4Kumada H. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C(SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma [J]. Oncology, 2002;62(1):94-100.
5Zhang L, Wang B. Randomized clinical trial with two doses (100 and 40 ml) of Stronger Neo-Minophagen C in Chinese patients with chronic hepatitis B [J]. Hepatol Res, 2002 ;24(3):220.
